Wenge Li

Title: Wenge Li: Innovator in Asymmetric Hydrogenation

Introduction

Wenge Li is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of chemistry, particularly in the area of asymmetric hydrogenation. With a total of 3 patents to his name, his work has implications for the development of pharmaceuticals.

Latest Patents

Wenge Li's latest patents include a process for preparing intermediates of peripherally-selective inhibitors of dopamine-β-hydroxylase. This innovative process involves catalytic asymmetric hydrogenation, which allows for the preparation of specific enantiomers of compounds. Another significant patent is an enantioselective process for cycloalkenyl β-substituted alanines. This process is crucial for creating enantiomerically enriched compounds that serve as key intermediates for ACE inhibitors such as ramipril and perindopril.

Career Highlights

Throughout his career, Wenge Li has worked with reputable companies, including Bial-Portela & Ca S.A. and Chiral Quest, Inc. His expertise in asymmetric synthesis has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Wenge Li has collaborated with notable professionals in his field, including David Alexander Learmonth and Alexander Beliaev. These collaborations have further enhanced his research and development efforts.

Conclusion

Wenge Li's contributions to asymmetric hydrogenation and his innovative processes have made a significant impact in the field of chemistry. His work continues to influence the development of important pharmaceutical compounds.